Amyotrophic Lateral Sclerosis Treatment Market

Mar 2021| MRS124A| Market Research Studies

Report Highlights

The report covers the overview about the amyotrophic lateral sclerosis disease, its type, and the possible treatment methods for curing the disease. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each type, drug, treatment, distribution channel and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional Amyotrophic Lateral Sclerosis Treatment markets; it explains the major market drivers of the Global Amyotrophic Lateral Sclerosis Treatment industry, current trends within the industry, major applications, and the regional dynamics of the Global Amyotrophic Lateral Sclerosis Treatment Market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the Global Amyotrophic Lateral Sclerosis Treatment Market.

Report Includes

  • 46 tables and 54 figures
  • An up-to-date analysis of the Global Amyotrophic Lateral Sclerosis Treatment Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Amyotrophic Lateral Sclerosis Treatment Market, and corresponding market share analysis by type, drug, treatment, distribution channel and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Amyotrophic Lateral Sclerosis Treatment, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new drugs and products still in the development and testing stages, and their probability of successful commercial launch within the next five years.
  • Impact of COVID-19 on the Amyotrophic Lateral Sclerosis Treatment Market as compared to overall global economy.
  • Insight into the growth development strategies of major Amyotrophic Lateral Sclerosis Treatment manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including Mitsubishi Tanabe Pharma Corporation, BrainStorm Cell Therapeutics Inc., Biogen Inc., Corestem Inc., AB Science SA and others.

Summary

Amyotrophic Lateral Sclerosis Treatment commonly referred to as Lou Gehrig's disease is a neurological disorder that mainly affects the neurons present in the central nervous system. These neurons are responsible for controlling the voluntary muscle movement in the body such as, talking, walking, or chewing. The person suffering from ALS disease faces certain symptoms such as, weakness, muscle twitching and even stiff muscles. Some of the prime reasons for the growth of amyotrophic lateral sclerosis treatment market are increasing number of geriatric populations thereby increasing the number of people suffering from ALS disease. Apart from this, increasing awareness among the population is further growing to bolster the market during the forecast period.

Recently, IonisPharma Pharmaceuticals, Inc. has established a scholarship program in greater San Diego to educate and help ALS patients by encouraging them in taking part in various physical and mental programs. As of now, there is no permanent cure for this disease but providing medications and undergoing surgery are some of the possible ways that can slow down the disease progression.

The global Amyotrophic Lateral Sclerosis Treatment Market was valued at $567.93 million in 2020 and is expected to witness a steady growth at a CAGR of 5.69%.

  • Table 1 : Global Amyotrophic Lateral Sclerosis Treatment Market, Through 2026
  • Table 2 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Type, Through 2026
  • Table 3 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Drug, Through 2026
  • Table 4 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Treatment, Through 2026
  • Table 5 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Distribution Channel, Through 2026
  • Table 6 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Region, Through 2026
  • Table 7 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Type, Through 2026
  • Table 8 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Drug, Through 2026
  • Table 9 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Treatment, Through 2026
  • Table 10 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Distribution Channel, Through 2026
  • Table 11 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Country, Through 2026
  • Table 12 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Type, Through 2026
  • Table 13 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Drug, Through 2026
  • Table 14 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Treatment, Through 2026
  • Table 15 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Distribution Channel, Through 2026
  • Table 16 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Country, Through 2026
  • Table 17 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Type, Through 2026
  • Table 18 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Drug, Through 2026
  • Table 19 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Treatment, Through 2026
  • Table 20 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Distribution Channel, Through 2026
  • Table 21 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Country, Through 2026
  • Table 22 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Type, Through 2026
  • Table 23 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Drug, Through 2026
  • Table 24 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Treatment, Through 2026
  • Table 25 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Distribution Channel, Through 2026
  • Table 26 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Country, Through 2026
  • Table 27 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Type, Through 2026
  • Table 28 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Drug, Through 2026
  • Table 29 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Treatment, Through 2026
  • Table 30 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Distribution Channel, Through 2026
  • Table 31 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Country, Through 2026
  • Table 32 : Mitsubishi Tanabe Pharma Corporation: Financial Performance, Through 2020
  • Table 33 : BrainStorm Cell Therapeutics Inc.: Financial Performance, Through 2020
  • Table 34 : Biogen Inc.: Financial Performance, Through 2020
  • Table 35 : Corestem Inc.: Financial Performance, Through 2020
  • Table 36 : AB Science SA: Financial Performance, Through 2020
  • Table 37 : Biohaven Pharmaceuticals, Inc.: Financial Performance, Through 2020
  • Table 38 : Sun Pharmaceutical Industries Ltd.: Financial Performance, Through 2020
  • Table 39 : Ionis Pharmaceuticals, Inc.: Financial Performance, Through 2020
  • Table 40 : Sanofi S.A.: Financial Performance, Through 2020
  • Table 41 : Amylyx Pharmaceuticals Inc.: Financial Performance, Through 2020
  • Table 42 : Otsuka Pharmaceutical Co., Ltd.: Financial Performance, Through 2020
  • Table 43 : GNT Pharma Co., Ltd.: Financial Performance, Through 2020
  • Table 44 : Bausch Health Companies Inc.: Financial Performance, Through 2020
  • Table 45 : Synthetic Biologics, Inc.: Financial Performance, Through 2020
  • Table 46 : Orphazyme A/S: Financial Performance, Through 2020
  • Figure 1 : Global Amyotrophic Lateral Sclerosis Treatment Market
  • Figure 2 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Value, 2019-2026
  • Figure 3 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Type, 2019-2026
  • Figure 4 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Drug, 2019-2026
  • Figure 5 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Treatment, 2019-2026
  • Figure 6 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Distribution Channel, 2019-2026
  • Figure 7 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Region, 2020
  • Figure 8 : Global Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Company, 2020
  • Figure 9 : Global Amyotrophic Lateral Sclerosis Treatment Market, Product Map, 2020
  • Figure 10 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Value, 2019-2026
  • Figure 11 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Type, 2019-2026
  • Figure 12 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Drug, 2019-2026
  • Figure 13 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Treatment, 2019-2026
  • Figure 14 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Distribution Channel, 2019-2026
  • Figure 15 : North America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Country, 2020
  • Figure 16 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Value, 2019-2026
  • Figure 17 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Type, 2019-2026
  • Figure 18 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Drug, 2019-2026
  • Figure 19 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Treatment, 2019-2026
  • Figure 20 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Distribution Channel, 2019-2026
  • Figure 21 : Europe Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Country, 2020
  • Figure 22 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Value, 2019-2026
  • Figure 23 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Type, 2019-2026
  • Figure 24 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Drug, 2019-2026
  • Figure 25 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Treatment, 2019-2026
  • Figure 26 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Distribution Channel, 2019-2026
  • Figure 27 : Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Country, 2020
  • Figure 28 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Value, 2019-2026
  • Figure 29 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Type, 2019-2026
  • Figure 30 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Drug, 2019-2026
  • Figure 31 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Treatment, 2019-2026
  • Figure 32 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Distribution Channel, 2019-2026
  • Figure 33 : South America Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Country, 2020
  • Figure 34 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Value, 2019-2026
  • Figure 35 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Type, 2019-2026
  • Figure 36 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Drug, 2019-2026
  • Figure 37 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Treatment, 2019-2026
  • Figure 38 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Distribution Channel, 2019-2026
  • Figure 39 : Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market, by Value, by Country, 2020
  • Figure 40 : Mitsubishi Tanabe Pharma Corporation: Revenue Share, 2020
  • Figure 41 : BrainStorm Cell Therapeutics Inc.: Revenue Share, 2020
  • Figure 42 : Biogen Inc.: Revenue Share, 2020
  • Figure 43 : Corestem Inc.: Revenue Share, 2020
  • Figure 44 : AB Science SA: Revenue Share, 2020
  • Figure 45 : Biohaven Pharmaceuticals, Inc.: Revenue Share, 2020
  • Figure 46 : Sun Pharmaceutical Industries Ltd.: Revenue Share, 2020
  • Figure 47 : Ionis Pharmaceuticals, Inc.: Revenue Share, 2020
  • Figure 48 : Sanofi S.A.: Revenue Share, 2020
  • Figure 49 : Amylyx Pharmaceuticals Inc.: Revenue Share, 2020
  • Figure 50 : Otsuka Pharmaceutical Co., Ltd.: Revenue Share, 2020
  • Figure 51 : GNT Pharma Co., Ltd.: Revenue Share, 2020
  • Figure 52 : Bausch Health Companies Inc.: Revenue Share, 2020
  • Figure 53 : Synthetic Biologics, Inc.: Revenue Share, 2020
  • Figure 54 : Orphazyme A/S: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report